Description

DSIP 10MG

We provide DSIP as a 10MG research peptide with a stated 99.1% purity. Furthermore, DSIP, also known as delta-sleep-inducing peptide, is a naturally occurring nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Consequently, researchers have investigated this peptide across sleep physiology, circadian regulation, neuroendocrine signaling, neurotransmitter activity, and stress-response research.

Key Attributes

• Brand: AvigenLab
• Product Name: DSIP
• Quantity: 10MG
• Stated Purity: 99.1%
• Molecular Type: Naturally Occurring Nonapeptide
• Full Name: Delta-Sleep-Inducing Peptide
• Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
• Sequence Length: 9 Amino Acids
• Product Format: Vial
• Classification: Research Use Only
• Human Use: Not For Human Use

DSIP Product Overview

We provide DSIP for research involving sleep physiology, neuropeptide signaling, circadian biology, and neuroendocrine regulation. Moreover, the peptide was originally isolated from cerebral venous blood and characterized as a nine-amino-acid peptide capable of influencing slow-wave EEG activity in experimental animal models.

Additionally, research has examined its broader biological effects on neurotransmitter concentrations, locomotor rhythms, hormonal activity, and stress-related physiological responses. Therefore, researchers can investigate the compound across several interconnected systems rather than limiting its study to sleep-related mechanisms alone.

You can explore additional research materials through our Online Store.

DSIP Product Identification

We identify DSIP as a 10MG research nonapeptide with a stated 99.1% purity. Furthermore, its established sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, giving the material a clearly defined nine-residue molecular structure.

Accordingly, researchers can reference the peptide through its name, sequence, quantity, purity designation, and vial configuration when organizing laboratory inventories or documenting experimental materials.

Product Category

We classify DSIP within our research peptide collection for sleep neuroscience, neuroendocrinology, and peptide biology. Accordingly, its scientific profile encompasses slow-wave sleep research, circadian regulation, neurotransmitter activity, hormonal signaling, and stress-response mechanisms.

Moreover, historical research identified DSIP as a peptide associated with delta-wave sleep activity, while later investigations expanded its research profile to include effects involving circadian rhythms, brain neurotransmitters, and endocrine signaling. Consequently, the peptide remains relevant to several areas of experimental neurobiology.

Scientific Characteristics

DSIP is a nine-amino-acid peptide with a molecular sequence of Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. In particular, researchers established its sequence through amino-acid analysis and chemical synthesis studies, demonstrating structure-specific biological activity in early experimental models.

Furthermore, research has detected DSIP-like material in the brain, hypothalamus, pituitary, peripheral tissues, cerebrospinal fluid, and plasma. Meanwhile, investigators have examined how the peptide may interact with neurotransmitter and endocrine systems. However, later reviews emphasize that the precise physiological role and endogenous mechanism of DSIP remain incompletely resolved.

Research Applications

We position DSIP for research involving slow-wave sleep, circadian rhythms, neuroendocrine signaling, neurotransmitter regulation, stress physiology, and peptide-mediated brain activity.

Additionally, researchers have examined DSIP in relation to GABAergic and other neurotransmitter systems, although published findings concerning its direct neurotransmitter effects remain inconsistent. Consequently, researchers continue to investigate the mechanisms rather than treating one proposed pathway as definitive.

Likewise, studies have investigated DSIP in relation to the hypothalamic-pituitary-adrenal axis. For example, one human study reported reduced ACTH-like immunoreactivity after intravenous DSIP administration, while another controlled study found no significant effect on CRH-stimulated ACTH or cortisol secretion. Therefore, the available evidence demonstrates an active research area with differing experimental findings rather than a single established mechanism.

Product Configuration

We provide DSIP in a 10MG vial carrying a stated 99.1% purity designation. Accordingly, the defined quantity, peptide identity, sequence, purity designation, and physical presentation create straightforward reference points for laboratory inventory and product documentation.

Moreover, the vial format allows researchers to distinguish this presentation from other peptide configurations within our collection. Therefore, product identification remains consistent across quantity, molecular identity, and research classification.

Product Features

The primary features include a 10MG quantity, 99.1% stated purity, nine-amino-acid peptide sequence, and clearly defined research-use presentation. Additionally, our product labeling identifies the material as Not For Human Use | Research Use Only.

Furthermore, the scientific literature gives DSIP a broad research profile encompassing sleep-related EEG activity, circadian regulation, neurotransmitter research, and endocrine signaling. As a result, the material provides researchers with a defined peptide for investigating several interconnected neurobiological processes.

Product Specifications

Intended Research Context

We identify DSIP as Research Use Only and Not For Human Use. Accordingly, our documentation focuses on laboratory investigation rather than therapeutic or consumer applications.

In particular, researchers can examine the peptide within experimental systems involving sleep physiology, circadian signaling, neuroendocrine regulation, neurotransmitter activity, and stress-related biological responses. Moreover, historical and contemporary studies have examined DSIP across animal and human research models, although results vary substantially according to experimental design and endpoint.

Nevertheless, researchers should distinguish experimental observations from established clinical conclusions. For example, studies investigating ACTH and cortisol responses have produced different findings, demonstrating why DSIP mechanisms require continued scientific investigation.

Packaging Information

We present the product in a clearly labeled 10MG vial featuring our AvigenLab product presentation. The packaging identifies the peptide, displays the 10MG quantity, and communicates the stated 99.1% Purity designation.

Additionally, the label communicates Not For Human Use | Research Use Only. Therefore, the packaging provides straightforward product identification while supporting consistent laboratory inventory and catalog organization.

Regulatory Information

We classify the product as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, scientific publications concerning DSIP do not constitute regulatory approval for this specific AvigenLab product presentation.

Moreover, although researchers have investigated DSIP in human and animal studies, the literature continues to describe unresolved questions concerning its physiological role, endogenous function, and mechanism of action. Consequently, we present the material according to its research classification and established scientific characteristics rather than making unsupported clinical claims.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Because peptide stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters.

Furthermore, researchers should maintain appropriate laboratory handling practices and follow the product-specific documentation associated with the material. Consequently, this approach supports consistent laboratory management without introducing assumptions about conditions that may vary between formulations.

Market Availability

Our DSIP presentation provides a defined 10MG research peptide configuration within our product collection. The product name, quantity, stated purity, nine-amino-acid sequence, vial format, and Research Use Only designation create clear reference points for laboratory inventory.

Moreover, the compound has a long-standing research history spanning sleep neuroscience, neuroendocrinology, circadian biology, and peptide physiology. Likewise, ongoing scientific discussion surrounding its mechanism keeps DSIP relevant to researchers investigating the relationship between neuropeptides, sleep, hormonal signaling, and brain physiology.

Product Reference

Our DSIP 10MG provides a defined nonapeptide research material with a stated 99.1% purity designation. We document the material according to its nine-amino-acid sequence, neuropeptide classification, product configuration, research applications, and Research Use Only status.

Consequently, the product provides researchers with a clearly characterized material for investigating slow-wave sleep mechanisms, circadian regulation, neurotransmitter activity, neuroendocrine signaling, and stress-related pathways. Furthermore, continuing research demonstrates that DSIP has a complex scientific profile, with several proposed mechanisms requiring further investigation.